Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration

Eyles, 1998, Intranasal administration of poly(lactic acid) microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse, Vaccine, 16, 698, 10.1016/S0264-410X(97)00249-1 Higaki, 1998, Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin, Vaccine, 16, 741, 10.1016/S0264-410X(97)00248-X Gebert, 1999, M cells at locations outside the gut, Semin. Immunol., 11, 165, 10.1006/smim.1999.0172 Neutra, 1996, Antigen sampling across epithelial barriers and induction of mucosal immune responses, Annu. Rev. Immunol., 14, 275, 10.1146/annurev.immunol.14.1.275 Perry, 1998, Immunology of the tonsils, Immunol. Today, 19, 414, 10.1016/S0167-5699(98)01307-3 Kuper, 1992, The role of nasopharyngeal lymphoid tissue, Immunol. Today, 13, 219, 10.1016/0167-5699(92)90158-4 Carr, 1996, Nasal-associated lymphoid tissue is an inductive site for rat tear IgA responses, Immunol. Invest., 25, 387, 10.3109/08820139609055728 Ridley Lathers, 1998, Inductive pathways leading to rat tear IgA antibody responses, Invest. Opthalmol. Vis. Sci., 39, 1005 Alpar, 1994, Microspheres absorption by the nasal mucosa of the rat, J. Drug Target, 3, 147, 10.3109/10611869409015903 Ebel, 1990, A method for quantifying particle absorption from the small intestine of the mouse, Pharm. Res., 7, 849, 10.1023/A:1015964916486 Asanuma, 1997, Isolation and characterization of mouse nasal-associated lymphoid tissue, .J Immunol. Methods, 202, 123, 10.1016/S0022-1759(96)00243-8 Tilney, 1971, Patterns of lymphatic drainage in the adult laboratory rat, J. Anat., 109, 369 Leary, 1995, Active immunisation with recombinant V antigen from Yersinia pestis protects mice against plague, Infect. Immun., 63, 2854, 10.1128/IAI.63.8.2854-2858.1995 Eyles, 1998, Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis subunit vaccines, Vaccine, 16, 2000, 10.1016/S0264-410X(98)00089-9 Spiers, 1999, Studies on the co-encapsulation, release and integrity of two subunit antigens: rV and rF1 from Yersinia pestis, J. Pharm. Pharmacol., 51, 991, 10.1211/0022357991773456 Czerkinsky, 1984, A solid phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody secreting cells, J. Immun. Meth., 65, 109, 10.1016/0022-1759(83)90308-3 Eyles, 1999, Immunological responses to nasal delivery of free and microencapsulated tetanus toxoid: studies on the effect of vehicle volume, Int. J. Pharm., 189, 75, 10.1016/S0378-5173(99)00239-2 Harmsen, 1985, The role of macrophages in particle translocation from lungs to lymph nodes, Science, 230, 1277, 10.1126/science.4071052 Alpar, 1998, Oral and nasal immunization with microencapsulated clinically relevant proteins, STP Pharm. Sci., 8, 41 Nugent, 1998, Design and delivery of non-parenteral vaccines, J. Clin. Pharm. Therapeut., 23, 257 O'Hagan, 1990, Absorption of peptides and proteins from the Respiratory tract and the potential for development of locally administered vaccine, Crit. Rev. Ther. Drug Carrier Sys., 7, 35 Patton, 1998, Deep lung delivery of proteins, Mod. Drug Discov., 5, 19 Lomotan, 1997, Aqueous-based microcapsules are detected primarily in gut-associated dendritic cells after oral inoculation of mice, Vaccine, 15, 1959, 10.1016/S0264-410X(97)00108-4 Schijns, 2000, Immunological concepts of vaccine adjuvant activity, Curr. Opin. Immunol., 12, 456, 10.1016/S0952-7915(00)00120-5 Zinkernagel, 1997, Antigen localization regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity, Immunol. Rev., 156, 199, 10.1111/j.1600-065X.1997.tb00969.x Benedetti, 1998, Oral administration of one dose of cholera toxin induces a systemic immune response prior to a mucosal immune response by a direct presentation in the spleen, Immunol. Lett., 60, 149, 10.1016/S0165-2478(97)00152-1 Wu, 1997, Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system, Immun. Res., 16, 187, 10.1007/BF02786362 Heritage, 1998, Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes, Immunology, 93, 249, 10.1046/j.1365-2567.1998.00420.x El-Baseir, 1998, Poly(l-lactic acid) microspheres for pulmonary drug delivery: release kinetics and aerosolization studies, Int. J. Pharm., 175, 135, 10.1016/S0378-5173(98)00246-4 Masinde, 1993, Aerosolized suspensions of poly(l-lactic acid) microspheres, Int. J. Pharm., 100, 123, 10.1016/0378-5173(93)90083-R Hensel, 1997, Vaccination by aerosols: modulation of clearance mechanisms by the lung, Behring Inst. Mitt., 98, 212 Schulz, 1998, Mechanisms and factors affecting intrapulmonary particle deposition: implications for efficient inhalation therapies, Pharm. Sci. Tech. Today, 1, 336, 10.1016/S1461-5347(98)00089-3 LiCalsi, 1999, Dry powder inhalation as a potential delivery method for vaccines, Vaccine, 17, 1796, 10.1016/S0264-410X(98)00438-1 Dilraj, 2000, Response to different measles vaccine strains given by aerosol and subcutaneous routes to children: a randomised trial, Lancet, 355, 798, 10.1016/S0140-6736(99)95140-1